<DOC>
	<DOCNO>NCT00065169</DOCNO>
	<brief_summary>The purpose study determine whether anti-inflammatory drug celecoxib delay onset Alzheimer Disease ( AD ) people Age Associated Memory Impairment ( AAMI ) . This study also evaluate genetic risk brain structure potential predictor mental decline .</brief_summary>
	<brief_title>Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs</brief_title>
	<detailed_description>AD one common mental disorder late life . Preliminary study indicate anti-inflammatory drug may attenuate prevent AD symptom , efficacy trial need . Participants study randomly assign receive either celecoxib placebo 18 month . Participants undergo positron emission tomography ( PET ) magnetic resonance imaging ( MRI ) scan brain . Routine laboratory blood test , cognitive test , electrocardiogram ( ECG ) perform . Participants also screen Parkinson disease . Follow-up testing conduct specific interval follow study .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>NIMH diagnostic criterion Age Associated Memory Impairment ( AAMI ) MiniMental State Examination ( MMSE ) score 26 30 ( unless &lt; 8 year educational achievement ) No significant cerebrovascular disease Estrogen replacement therapy thyroid replacement therapy ( participant euthyroid ) permit therapy stable &gt; 1 month Memory verbal fluency cutoff score increase probability incipient dementia ( BuschkeFuld : 34 ; verbal fluency : 46 letter , 7 category ; Benton Visual Retention : 5 ) Adequate visual auditory acuity allow neuropsychological test Normal screen laboratory test electrocardiogram ( ECG ) Possible probable Alzheimer Disease ( AD ) dementia Neurologic physical illness could produce cognitive deterioration History transient ischemic attack ( TIAs ) , carotid bruits , lacunes MRI scan History myocardial infarction within previous year unstable cardiac disease Uncontrolled hypertension ( systolic BP &gt; 170 diastolic BP &gt; 100 ) History significant liver disease , pulmonary disease , diabetes , cancer DSMIV criterion major psychiatric disorder within previous 2 year Past present history alcoholism drug dependence Untreated depression determine Hamilton Depression Rating Scale ( HAMD ) score 12 Drugs may significantly affect psychometric test result Centrally active betablockers , narcotic , clonidine , antiParkinsonian medication , antipsychotic , benzodiazepine , systemic corticosteroid , medication significant cholinergic anticholinergic effect , anticonvulsant , warfarin , vitamins standard multivitamin supplement , ginkgo biloba , nutraceuticals . Occasional chloral hydrate use allow , discourage , insomnia . Investigational drug within previous month longer , depend drug halflife Contraindication MRI scan ( e.g. , metal body , claustrophobia )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>